Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/noz175.558
- Subjects: ENSAIO CLÍNICO; MENINGIOMA; GLÂNDULA PITUITÁRIA; NEOPLASIAS CEREBRAIS; ASTROCITOMA
- Language: Inglês
- Imprenta:
- Publisher: Society for Neuro-Oncology
- Publisher place: Oxford
- Date published: 2019
- Source:
- Título do periódico: Neuro-oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 21, suppl. 6, res. INNV-15, p. vi133, 2019
- Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 16 abr. 2024. , 2019 -
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558 -
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1093/neuonc/noz175.558 -
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1093/neuonc/noz175.558 - Charting epigenomic signatures in CpG island methylator phenotype (CIMP) tumors
- Whole genome DNA is distinctly methylated in functioning and non-functioning pituitary macroadenomas
- The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- The cancer genome atlas pan-cancer analysis project
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
- Src as a novel therapeutic target for endometriosis
- Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon
- Methylation-based liquid biopsy of meningioma primary and recurrent samples
Informações sobre o DOI: 10.1093/neuonc/noz175.558 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
